Narula Sanjeev
SEC insider (Form 3/4/5 filer). CIK 0001820590. Chief Financial & Bus. Officer at Phathom Pharmaceuticals, Inc. (PHAT) and 1 other issuer. 8 reported Form 4/5 transactions since Sep 2024; latest on Oct 6, 2026. Located in FLORHAM PARK, NJ.
Companies Narula Sanjeev has filed insider reports for
- Phathom Pharmaceuticals, Inc. (PHAT): Officer, Chief Financial & Bus. Officer
- Intra-Cellular Therapies, Inc. (ITCI): Officer, Executive Vice President & CFO
Narula Sanjeev
CIK: 0001820590
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (8 total)
- Oct 6, 2026PHAT
Phathom Pharmaceuticals, Inc.
Tax PaymentDirect13.5K shares at avg. $6.78$91K - Jan 2, 2026PHAT
Phathom Pharmaceuticals, Inc.
AwardDirect82.7K shares- - Oct 6, 2025PHAT
Phathom Pharmaceuticals, Inc.
AwardDirect144K shares- - Oct 6, 2025PHAT
Phathom Pharmaceuticals, Inc.
AwardDirectStock Option (Right to Buy)
200K shares- - Apr 2, 2025ITCI
Intra-Cellular Therapies, Inc.
DispositionDirectStock Option (right to buy)
17.3K shares- - Apr 2, 2025ITCI
Intra-Cellular Therapies, Inc.
DispositionDirectRestricted Stock Units
35K shares- - Apr 2, 2025ITCI
Intra-Cellular Therapies, Inc.
DispositionDirectRestricted Stock Units
22.7K shares- - Feb 3, 2025ITCI
Intra-Cellular Therapies, Inc.
AwardDirectRestricted Stock Units
22.7K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 6, 2026 |  PHAT Phathom Pharmaceuticals, Inc. | Tax Payment | 13,485 | $6.78 | $91,428 | Direct |
| Jan 2, 2026 | PHAT Phathom Pharmaceuticals, Inc. | Award | 82,715 | - | $0 | Direct |
| Oct 6, 2025 | PHAT Phathom Pharmaceuticals, Inc. | Award | 144,000 | - | - | Direct |
| Oct 6, 2025 | PHAT Phathom Pharmaceuticals, Inc. | Award Stock Option (Right to Buy) | 200,000 | - | - | Direct |
| Apr 2, 2025 |  ITCI Intra-Cellular Therapies, Inc. | Disposition Stock Option (right to buy) | 17,251 | - | - | Direct |
| Apr 2, 2025 | ITCI Intra-Cellular Therapies, Inc. | Disposition Restricted Stock Units | 35,046 | - | - | Direct |
| Apr 2, 2025 | ITCI Intra-Cellular Therapies, Inc. | Disposition Restricted Stock Units | 22,727 | - | - | Direct |
| Feb 3, 2025 | ITCI Intra-Cellular Therapies, Inc. | Award Restricted Stock Units | 22,727 | - | - | Direct |
1-8 of 8 transactions